|
MRPS14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.02691246803988E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.436000E-01 |
| Stage1-vs-Stage3 |
6.436800E-01 |
| Stage1-vs-Stage4 |
4.538000E-02 |
| Stage2-vs-Stage3 |
3.290400E-01 |
| Stage2-vs-Stage4 |
3.224300E-02 |
| Stage3-vs-Stage4 |
1.394220E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.29890004202582E-09 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
6.222100E-02 |
| Caucasian-vs-Asian |
4.698400E-01 |
| AfricanAmerican-vs-Asian |
2.087800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.960400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.5577999999713E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.398800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.826000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.497000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.354600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.938200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.106800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.340000E-03 |
| Classical-VS-Follicular |
2.497200E-01 |
| Classical-VS-Other |
2.174600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.357600E-03 |
| Tall-VS-Other |
9.026000E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
1.996370E-01 |
| Follicular-VS-Normal |
1.64335212105016E-12 |
| Other-VS-Normal |
7.38609999828554E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
9.723300E-03 |
|
|
